Thus, it was readily predictable that up-regulation of the immune check point proteins, programmed cell death protein 1 ligand 1 (PD-L1) and CTLA-4 would prevent T-cell activation [25] since these proteins represented likely targets for restoring normal T-cell proliferation in RA [26]. Here, CTLA4 is linked to rheumatoid arthritis.